Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
US8785632B2 · kind B2 · utility
3Cited by
32References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 29, 2012 |
| Grant date | Jul 22, 2014 |
| Priority date | — |
| Expiry date | Jun 29, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Enantiomerically pure compound of formula 1are provided, as well as methods for their synthesis and use. Preferred compounds are potent inhibitors of the c-Met protein kinase, and are useful in the treatment of abnormal cell growth disorders, such as cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.